Related Experiment Video
Updated: May 11, 2026
23:56
Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
Published on: October 31, 2010
Pediatric pathology services in Africa.
Darcy A Kerr1, Ronald Otto Christian Kaschula
1Department of Pathology, Massachusetts General Hospital, Boston, MA, USA.
Archives of Pathology & Laboratory Medicine
|June 1, 2013
Summary
Pediatric pathology in Africa faces resource limitations. This review offers guidance on diagnosing pediatric cancers, aiming to improve care for children in low-resource settings.
Area of Science:
- Pediatric Pathology
- Oncology
- Global Health
Background:
- Limited resources and professional development opportunities challenge pediatric pathology services in Africa.
- A high burden of pediatric diseases, including rare neoplasms, strains general pathologists' expertise in the region.
- Incomplete specialized training exacerbates difficulties in providing high-quality pediatric pathology services.
Purpose of the Study:
- To deliver essential pediatric pathology information, focusing on pediatric malignancies.
- To support pathologists in Africa, where children constitute a significant population segment and pediatric pathology training is limited.
Main Methods:
- Review of authors' extensive experience in pediatric pathology.
- Synthesis of relevant scientific literature and clinical data.
Main Results:
- Effective specimen triaging and strategic use of cytology can mitigate resource limitations.
- Collaboration within Africa and internationally is crucial for advancing diagnostic capabilities.
- Addressing pediatric neoplasms requires specific attention due to their diagnostic challenges.
Conclusions:
- Thoughtful specimen management and cost-effective diagnostic methods like cytology are key.
- Enhanced investment in child health infrastructure, including dedicated pediatric hospitals, is vital.
- Strengthening pediatric pathology services is essential for improving child health outcomes in Africa.
Related Concept Videos
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
01:22Lysosomal Hydrolases
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...